Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death.
Ontology highlight
ABSTRACT: Over half of all cancer patients undergo radiation therapy but there is an unmet need for more efficacious combination strategies with molecular targeted drugs. DNA damage response has emerged as an important intervention point for improving anti-tumor effects of radiation and several inhibitors are currently in development. Ataxia telangiectasia mutated (ATM) kinase is a key regulator of cellular response to DNA double strand breaks and a potential target for radiosensitization. We recently reported two new potent and selective ATM inhibitors, M3541 and M4076, that effectively sensitize cancer cells to radiation and regress human xenografts in clinically relevant animal models. Here, we dive deeper into the cellular events in irradiated cancer cells exposed to ATM inhibitors. Suppression
SUBMITTER: Chiu LY
PROVIDER: S-EPMC9925676 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA